Contact Cerephex for more information
Contact Cerephex for more information
Read more about current chronic pain science
Read more about Cerephex's technology and clinical research
Read more about Cerephex's product NeuroPoint
Cerephex plans to
commercialize the NeuroPoint®
platform after receiving FDA
approval for the indication of
treatment of pain in the central
pain condition fibromyalgia
Solutions for Chronic Pain

Cerephex Corporation is a privately held medical device
company focused on developing therapies and diagnostic
technologies for chronic pain.

Cerephex's current focus is on noninvasive brain
stimulation therapy as a treatment for fibromyalgia and
other central pain conditions.
Noninvasive Technology and Medical Device for Centralized Pain
Chronic Pain
Cerephex® is leveraging
emerging science about
centralization of pain and
developing technologies in
response to changing
paradigms in chronic pain care
Technology / Research
Cerephex's proprietary
noninvasive cortical
stimulation treatment
technology has been tested in
a multicenter human clinical
trial on fibromyalgia patients
Product
All information © 2011-2015 Cerephex Corporation
Cerephex, NeuroPoint and RINCE are all trademarks of Cerephex Corporation